Rocket Pharmaceuticals RCKT
NASDAQ RCKT
$2.63 +0.04 (+1.54%)
At close: Sep 30, 2026 · 4:00 PM EDT

Rocket Pharmaceuticals (RCKT) Non-Current Assets (2014 - 2026)

Updated

Rocket Pharmaceuticals (RCKT) posted Non-Current Assets of $133.55 million for Q2 2026, down 7.1% from $143.82 million a year earlier and down 1.5% from the prior quarter.

Analysis

Rocket Pharmaceuticals (RCKT) Non-Current Assets (2014 - 2026) Analysis & Trends

At the end of FY2025, Rocket Pharmaceuticals' Non-Current Assets came in at $137.72 million, down 7.9% from FY2024.

  • Annual Non-Current Assets shows a five-year compound annual growth rate of 5.9% (FY2020 to FY2025).
  • In prior years, Rocket Pharmaceuticals' Non-Current Assets was $149.52 million in FY2024 (-20.5%), $188.12 million in FY2023 (+0.2%), $187.75 million in FY2022 (+78.9%) and $104.96 million in FY2021 (+1.4%).
  • The Q2 2026 figure stands as the lowest quarterly Non-Current Assets since Q3 2022.
  • On a year-over-year basis, Non-Current Assets has declined in each of the last seven quarters, with an average decline of 7.8% over the last eight quarters.
  • The strongest year-over-year quarter for Non-Current Assets in the past five years was Q4 2022, with growth of 78.9%; the weakest was Q4 2024, with a decline of 20.5%.
  • According to Business Quant data, Non-Current Assets for the three prior quarters was $135.58 million (Q1 2026), $137.72 million (Q4 2025) and $140.35 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 141.29 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 101.45 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 87.87 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 35.42 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 14.88 Bn
10 Rocket Pharmaceuticals 283.71 Mn 283.71 Mn - 133.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 133.55 Mn
Mar 31, 2026 135.58 Mn
Dec 31, 2025 137.72 Mn
Sep 30, 2025 140.35 Mn
Jun 30, 2025 143.82 Mn
Mar 31, 2025 146.57 Mn
Dec 31, 2024 149.52 Mn
Sep 30, 2024 151.93 Mn
Jun 30, 2024 153.69 Mn
Mar 31, 2024 154.28 Mn
Dec 31, 2023 188.12 Mn
Sep 30, 2023 151.90 Mn
Jun 30, 2023 149.71 Mn
Mar 31, 2023 176.72 Mn
Dec 31, 2022 187.75 Mn
Sep 30, 2022 106.13 Mn
Jun 30, 2022 106.08 Mn
Mar 31, 2022 106.30 Mn
Dec 31, 2021 104.96 Mn
Sep 30, 2021 105.17 Mn
API Access

Rocket Pharmaceuticals Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=RCKT&period=max&api_key=YOUR_API_KEY